Product information
From Health Canada
Current status:
Cancelled Pre Market
Product name:
MIRALUMA
DIN:
Not Applicable Electronic product monograph is not available
Company:
LANTHEUS MI CANADA INC
1111 Dr. Frederik-Philips Blvd., Suite 600
Montreal
Quebec
Canada
H4M 2X6
Class:
Radiopharmaceutical
Dosage form(s):
Powder For Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Schedule C
American Hospital Formulary Service (AHFS): See footnote 3
Anatomical Therapeutic Chemical (ATC): See footnote 4
Active ingredient group (AIG) number:See footnote5
0152590001
Active ingredient(s) | Strength |
---|---|
TETRAKIS [CU(MIBI)4]BF4 | 1 MG / VIAL |